|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.09 EUR | -0.35% |
|
+0.40% | -8.37% |
| 07-10 | Sanofi Receives Fda Approval for Subcutaneous Sarclisa Escena Administered Via On-Body Injector | CI |
| 07-10 | Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena in Multiple Myeloma | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SAN Stock
- 1SAN Stock
- Charts Sanofi
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
